Oxley

CytoSorbents Appoints Alexander D’Amico as Chief Financial Officer

Retrieved on: 
Wednesday, July 19, 2023
Cognizant, Quest Diagnostics, CSE, Oxley, Information technology, Software, Cytokine adsorbing column, Certified Public Accountant, American Institute of Certified Public Accountants, Sarbanes–Oxley Act, Chartered Global Management Accountant, Shared services, Alexander, Sale, Professional corporation, Rutgers University, Alex, Magnite Inc, Secretary of State of New Jersey, Retirement, Acquisition, Fortune 500, Risk, Brother Industries, Sarbanes, BASF, Cytosorbents Corporation, CFO, COE, Growth, American Institute, Security (finance), Quest

PRINCETON, N.J., July 19, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, announced the appointment of Alexander D’Amico as Chief Financial Officer, to begin employment on August 7, 2023.

Key Points: 
  • PRINCETON, N.J., July 19, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, announced the appointment of Alexander D’Amico as Chief Financial Officer, to begin employment on August 7, 2023.
  • Mr. D’Amico brings over 20 years of broad finance, SEC reporting, merger and acquisition, fundraising, and accounting experience to CytoSorbents.
  • At Quest, he also led the introduction, standardization, and centralization of the Sarbanes Oxley methodology to global markets.
  • Dr. Phillip Chan, Chief Executive Officer of CytoSorbents, stated, “We are thrilled to bring Alex on as Chief Financial Officer and as a key member of the CytoSorbents management team.

Brain-computer interface to control digital devices using thoughts: The European Patent Office has announced that Australian researchers have been selected as finalists for the European Inventor Award 2023

Retrieved on: 
Tuesday, May 30, 2023
Epilepsy, Surgeon, United Nations, Oxley, Locomotion, Stroke, DSM-IV codes, Quality of life, DRS, Skull, Brain, Research, Interface (computing), Movement, EPO, Paralysis, Blood, Alzheimer's disease, Motor cortex, Parkinson's disease, Patient, United, Invention, European Inventor Award, Migraine, Medical device, Medical imaging, Opie, Stent-electrode recording array, Beckman Coulter, European

In an effort to improve the quality of life for those affected, Australian researchers Drs.

Key Points: 
  • In an effort to improve the quality of life for those affected, Australian researchers Drs.
  • Thomas Oxley and Nicholas Opie invented a brain-computer interface system that transmits data from the brain wirelessly to control external digital devices hands-free, to enable patients with severe paralysis to communicate using their thoughts.
  • The research duo are finalists for the European Inventor Award in the 'Non-EPO Countries' category in recognition of their promising work.
  • The winners will be announced at a hybrid ceremony on 4 July 2023 in Valencia (Spain).

Journey Medical Corporation Appoints Joseph Benesch as Interim Chief Financial Officer

Retrieved on: 
Friday, January 20, 2023
Torrent, Entrepreneurship, GAAP, Ernst, Torrent Group, Aptalis, Savient pharmaceuticals, NDA, Certified Public Accountant, Wilkes University, LLP, BA, Market for corporate control, Interim, Oxley, Torrent Pharmaceuticals, Pleasure, Sarbanes, Pharmaceutical industry, Finance

The Company also today announced the appointment of Joseph M. Benesch as Interim Chief Financial Officer, effective January 27, 2023.

Key Points: 
  • The Company also today announced the appointment of Joseph M. Benesch as Interim Chief Financial Officer, effective January 27, 2023.
  • Claude Maraoui, Co-Founder, President and Chief Executive Officer of Journey Medical, said, “Joe has been an instrumental member of our finance and accounting team overseeing all functions as Corporate Controller for over a year now.
  • Mr. Maraoui continued, "We want to thank Ernie for his contributions to the Company as Chief Financial Officer.
  • "I look forward to continuing to work with the Journey Medical management team while leading the finance and accounting functions,” commented Mr. Benesch.

Sarbanes Oxley Compliance Resource Kit Silver Edition 2022 - Comply With IT Governance Requirements - ResearchAndMarkets.com

Retrieved on: 
Friday, December 2, 2022
Technology, Security, Policy, Service Request Block, Beyoncé: Platinum Edition, Sarbanes, Best practice, Change management, Sarbanes–Oxley Act, SOX, ISO, Classification, COBIT, Electronic paper, ITIL, Internet, Business, Enterprise, Risk, Documentation, Oxley, Change, Audit, Risk management, Platinum, Silver, Gold

The "Sarbanes Oxley Compliance Resource Kit - Silver Edition" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Sarbanes Oxley Compliance Resource Kit - Silver Edition" report has been added to ResearchAndMarkets.com's offering.
  • The Sarbanes Oxley Compliance Resource Kit Silver Edition is almost 25% off of the list price of the individual components.
  • The SOX kit contains all of the tools that are need to comply with the Sarbanes-Oxley legislation.
  • ITIL and "Best Practices" are no longer sufficient to conform to the Sarbanes Oxley and COBIT requirements.

2022 Sarbanes Oxley Compliance Resource Kit: A Vehicle to Comply with the IT Governance Requirements

Retrieved on: 
Wednesday, November 30, 2022
Risk, Policy, ITIL, SOX, Classification, Change management, COBIT, Oxley, Change, Documentation, Sarbanes–Oxley Act, Sarbanes, Electronic paper, Service Request Block, Enterprise, Best practice, Audit, Risk management

DUBLIN, Nov. 30, 2022 /PRNewswire/ -- The "Sarbanes Oxley Compliance Resource Kit" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Nov. 30, 2022 /PRNewswire/ -- The "Sarbanes Oxley Compliance Resource Kit" report has been added to ResearchAndMarkets.com's offering.
  • The SOX kit contains all of the tools that are need to comply with the Sarbanes-Oxley legislation.
  • ITIL and "Best Practices" are no longer sufficient to conform to the Sarbanes Oxley and COBIT requirements.
  • The Sarbanes Oxley Compliance Resource Kit includes the following components:

2022 Sarbanes Oxley Compliance Resource Kit - ResearchAndMarkets.com

Retrieved on: 
Thursday, November 24, 2022
Professional Services, Legal, Finance, Change management, Sarbanes–Oxley Act, Best practice, Enterprise, Service Request Block, Change, Policy, SOX, ITIL, Classification, Documentation, Oxley, COBIT, Electronic paper, Risk, Sarbanes, Audit, Risk management

The "Sarbanes Oxley Compliance Resource Kit" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Sarbanes Oxley Compliance Resource Kit" report has been added to ResearchAndMarkets.com's offering.
  • The SOX kit contains all of the tools that are need to comply with the Sarbanes-Oxley legislation.
  • ITIL and "Best Practices" are no longer sufficient to conform to the Sarbanes Oxley and COBIT requirements.
  • The Sarbanes Oxley Compliance Resource Kit includes the following components:

Sonida Senior Living Names Kevin Detz Chief Financial Officer

Retrieved on: 
Wednesday, April 13, 2022
Residential Building & Real Estate, Construction & Property, Seniors, Consumer, Goldman Sachs, Ageing, Family, CEO, Duquesne University, Aimbridge Hospitality, Oxley, Sarbanes–Oxley Act, SNDA, Operational definition, CPA, Isabella, Leadership, AICPA, Organization, Controller, Ernst & Young, Mission statement, Growth, Efficiency, Company, Sarbanes, Certified Public Accountant, SEC, NYSE, Forecasting, Management, Sound

Sonida Senior Living Corporation (NYSE: SNDA), one of the nations leading senior living owner-operators, announced the appointment of Kevin Detz, CPA, as Chief Financial Officer, effective May 1, 2022.

Key Points: 
  • Sonida Senior Living Corporation (NYSE: SNDA), one of the nations leading senior living owner-operators, announced the appointment of Kevin Detz, CPA, as Chief Financial Officer, effective May 1, 2022.
  • Detz joins Sonida from Aimbridge Hospitality, the leading third-party global hotel management company, where he most recently served as Executive Vice President and Operational Chief Financial Officer.
  • From January 2020 to April 2022, Detz served as Executive Vice President and Operational Chief Financial Officer, where he was responsible for leading the companys corporate and operational accounting and reporting functions.
  • Dallas-based Sonida Senior Living is one of the nations leading operators of independent living, assisted living and memory care communities for senior adults.

Community Redevelopment Adds Jeanne Freddura to The Newly Created Position of Senior Vice President of Finance and Development

Retrieved on: 
Wednesday, February 2, 2022
Growth, Fifth Ward Community Redevelopment Corporation, Community, Leadership, Government, Private Securities Litigation Reform Act, Oxley, High tech, Policy, SEC, Development, BA, Accounting, Report, Market for corporate control, Sarbanes, MS, Medication, Administration, Harvard University, U.S. Securities and Exchange Commission, Cambridge College, Company, Financial management, Ernst, GLOBE, Ownership, IPO, Senior, Time, Security (finance), Finance & Development, OTC, Property management, Management, Southeastern United States, Retail

We welcome Jeanne to Community Redevelopment and look forward to her contributions to the growth of the company.

Key Points: 
  • We welcome Jeanne to Community Redevelopment and look forward to her contributions to the growth of the company.
  • We are committed to further elevating the experience of doing business with Community Redevelopment as we grow together."
  • Jeanne Freddura, Senior Vice President of Finance and Development, said, I am very excited to be joining Community Redevelopment and its great leadership team, at such a pivotal time in the growth of the company.
  • Jeanne Freddura comes to Community Redevelopment with over 25 years of finance experience in a diverse set of industries, such as Pharmaceuticals, Biotechnologies, Research & Development, Retail, and High Technology.